The South & Central America kidney disease market is expected to reach US$ 9,060.9 million in 2027 from US$ 5,758.9 million in 2019. The market is estimated to grow with a CAGR of 5.9% from 2020-2027.
Kidney disease means that the kidneys are damaged and cannot filter blood as they should. This damage can cause wastes to build up in your body. Diabetes and high blood pressure are the most common causes of kidney disease. There are various types of kidney diseases including kidney stones, glomerulonephritis, urinary tract infections, and others.The scope of the kidney disease market includes product, end-user, and region.
Brazil Kidney Disease Market Revenue and Forecasts to 2027 (US$ MN)

- This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.
Market Insights
Increased Contribution by the Governments of the Countries
Every government of the countries in the South & Central America region is now focusing on boosting the healthcare sector and fund various programs to raise awareness about kidney diseases. As per the report published in December 2018 called‘ Kidney disease in Latin America: current status, challenges, and the role of the ISN in the development of nephrology in the region,’ concerning capacity building and education, an average of 10 to 11 nephrologists have been trained yearly under the ISN(International Society of Nephrology) Fellowship Program support. Besides, from 2009 to 2017, the region graduated 4 Sister Renal Center programs (a program designed to nurture a partnership between centers by supplying a framework and list of benefits) while 6 remain active. Centers have received eight grants from the ISN Clinical Research Program since 2010 to support projects that may help understand the local reality and test strategies addressing regional challenges. It implies intraregional support from those with higher development and capacity to those in greater need of generating highly qualified human resources. The ISN has identified a series of regional centers of excellence, identified as sites that can and should offer support in training for clinical or research purposes. Thus, an increase in the contribution of the government of the countries is likely to create lucrative opportunities for market growth.
Product- Based Market Insights
Based on product,thekidney disease marketis segmented into diagnosis and treatment. The diagnosis segment held the largest share of the market in 2019, also the same segment is anticipated to register the highest CAGR in the market during the forecast period.
End-User - Based Market Insights
Based on end-user, the kidney disease market, is segmented into hospitals, diagnostic laboratories, and others. The hospitals segment held the largest share of the market in 2019, also the same segment is anticipated to register the highest CAGR in the market during the forecast period.
South & Central America Kidney Disease Market, by End-User – 2019 and 2027

- This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.
Customize This Report To Suit Your Requirement
You will get customization on any report - free of charge - including parts of this report, or country-level analysis, Excel Data pack, as well as avail great offers and discounts for start-ups & universities
South and Central America Kidney Disease Market: Strategic Insights

- Get Top Key Market Trends of this report.This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.
You will get customization on any report - free of charge - including parts of this report, or country-level analysis, Excel Data pack, as well as avail great offers and discounts for start-ups & universities
South and Central America Kidney Disease Market: Strategic Insights

- Get Top Key Market Trends of this report.This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.
Product launches and approvals are commonly adopted strategies by companies to expand their footprint worldwide and meet the growing demand. The players operating in the kidney disease market adopt the expansion, collaboration, and product launch strategies to enlarge customer base across the world. These strategies allow the players to maintain their brand name globally. For instance,In September 2020, F. Hoffmann-La Roche Ltd. acquired a biotech firm,Inflazome. This acquisition will grant Roche full rights to Inflazome's portfolio of clinical and pre-clinical NLRP3 inhibitors. The business plans to develop NLRP3 inhibitors in a variety of indications.
SOUTH & CENTRAL AMERICAKIDNEY DISEASE MARKET SEGMENTATION
- Diagnosis
o Blood Tests
o Urine Tests
o Imaging Tests
o Others
- Treatment
o Dialysis
o Others
o Drug Class
- ACE Inhibitors
- Angiotensin-II Receptor Blockers
- Diuretics
- Others
By End User
- Hospitals
- Diagnostic Laboratories
- Others
- South & Central America
o Brazil
o Argentina
Company Profiles
- Abbott
- F. Hoffmann-La Roche Ltd
- AbbVie Inc
- Pfizer Inc
- Teva Pharmaceutical Industries Ltd
- GlaxoSmithKline plc
- Sysmex Corporation
- Siemens AG
- Amgen Inc
South and Central America Kidney Disease Market Regional Insights
The regional trends and factors influencing the South and Central America Kidney Disease Market throughout the forecast period have been thoroughly explained by the analysts at Insight Partners. This section also discusses South and Central America Kidney Disease Market segments and geography across North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America.

- Get the Regional Specific Data for South and Central America Kidney Disease Market
South and Central America Kidney Disease Market Report Scope
Report Attribute | Details |
---|---|
Market size in 2019 | US$ 5,758.9 Million |
Market Size by 2027 | US$ 9,060.9 Million |
Global CAGR (2020 - 2027) | 5.9% |
Historical Data | 2017-2018 |
Forecast period | 2020-2027 |
Segments Covered |
By Product
|
Regions and Countries Covered | South and Central America
|
Market leaders and key company profiles |
South and Central America Kidney Disease Market Players Density: Understanding Its Impact on Business Dynamics
The South and Central America Kidney Disease Market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.
Market players density refers to the distribution of firms or companies operating within a particular market or industry. It indicates how many competitors (market players) are present in a given market space relative to its size or total market value.
Major Companies operating in the South and Central America Kidney Disease Market are:
- Abbott
- F. Hoffmann-La Roche Ltd
- AbbVie Inc.
- Pfizer Inc.
- Teva Pharmaceutical Industries Ltd
Disclaimer: The companies listed above are not ranked in any particular order.

- Get the South and Central America Kidney Disease Market top key players overview
- Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
- PEST and SWOT Analysis
- Market Size Value / Volume - Global, Regional, Country
- Industry and Competitive Landscape
- Excel Dataset
Testimonials
Reason to Buy
- Informed Decision-Making
- Understanding Market Dynamics
- Competitive Analysis
- Identifying Emerging Markets
- Customer Insights
- Market Forecasts
- Risk Mitigation
- Boosting Operational Efficiency
- Strategic Planning
- Investment Justification
- Tracking Industry Innovations
- Aligning with Regulatory Trends
Yes! We provide a free sample of the report, which includes Report Scope (Table of Contents), report structure, and selected insights to help you assess the value of the full report. Please click on the "Download Sample" button or contact us to receive your copy.
Absolutely — analyst assistance is part of the package. You can connect with our analyst post-purchase to clarify report insights, methodology or discuss how the findings apply to your business needs.
Once your order is successfully placed, you will receive a confirmation email along with your invoice.
• For published reports: You’ll receive access to the report within 4–6 working hours via a secured email sent to your email.
• For upcoming reports: Your order will be recorded as a pre-booking. Our team will share the estimated release date and keep you informed of any updates. As soon as the report is published, it will be delivered to your registered email.
We offer customization options to align the report with your specific objectives. Whether you need deeper insights into a particular region, industry segment, competitor analysis, or data cut, our research team can tailor the report accordingly. Please share your requirements with us, and we’ll be happy to provide a customized proposal or scope.
The report is available in either PDF format or as an Excel dataset, depending on the license you choose.
The PDF version provides the full analysis and visuals in a ready-to-read format. The Excel dataset includes all underlying data tables for easy manipulation and further analysis.
Please review the license options at checkout or contact us to confirm which formats are included with your purchase.
Our payment process is fully secure and PCI-DSS compliant.
We use trusted and encrypted payment gateways to ensure that all transactions are protected with industry-standard SSL encryption. Your payment details are never stored on our servers and are handled securely by certified third-party processors.
You can make your purchase with confidence, knowing your personal and financial information is safe with us.
Yes, we do offer special pricing for bulk purchases.
If you're interested in purchasing multiple reports, we’re happy to provide a customized bundle offer or volume-based discount tailored to your needs. Please contact our sales team with the list of reports you’re considering, and we’ll share a personalized quote.
Yes, absolutely.
Our team is available to help you make an informed decision. Whether you have questions about the report’s scope, methodology, customization options, or which license suits you best, we’re here to assist. Please reach out to us at sales@theinsightpartners.com, and one of our representatives will get in touch promptly.
Yes, a billing invoice will be automatically generated and sent to your registered email upon successful completion of your purchase.
If you need the invoice in a specific format or require additional details (such as company name, GST, or VAT information), feel free to contact us, and we’ll be happy to assist.
Yes, certainly.
If you encounter any difficulties accessing or receiving your report, our support team is ready to assist you. Simply reach out to us via email or live chat with your order information, and we’ll ensure the issue is resolved quickly so you can access your report without interruption.















The List of Companies - South and Central America Kidney Disease Market
- Abbott
- F. Hoffmann-La Roche Ltd
- AbbVie Inc.
- Pfizer Inc.
- Teva Pharmaceutical Industries Ltd
- GlaxoSmithKline plc.
- Sysmex Corporation
- Siemens AG
- Amgen Inc.


